The Landscape of Non-Viral Gene Augmentation Strategies for Inherited Retinal Diseases

Inherited retinal diseases (IRDs) are a heterogeneous group of disorders causing progressive loss of vision, affecting approximately one in 1000 people worldwide. Gene augmentation therapy, which typically involves using adeno-associated viral vectors for delivery of healthy gene copies to affected tissues, has shown great promise as a strategy for the treatment of IRDs. However, the use of viruses is associated with several limitations, including harmful immune responses, genome integration, and limited gene carrying capacity. Here, we review the advances in non-viral gene augmentation strategies, such as the use of plasmids with minimal bacterial backbones and scaffold/matrix attachment region (S/MAR) sequences, that have the capability to overcome these weaknesses by accommodating genes of any size and maintaining episomal transgene expression with a lower risk of eliciting an immune response. Low retinal transfection rates remain a limitation, but various strategies, including coupling the DNA with different types of chemical vehicles (nanoparticles) and the use of electrical methods such as iontophoresis and electrotransfection to aid cell entry, have shown promise in preclinical studies. Non-viral gene therapy may offer a safer and effective option for future treatment of IRDs

USH2A-retinopathy: From genetics to therapeutics

Bilallelic variants in the USH2A gene can cause Usher syndrome type 2 and non-syndromic retinitis pigmentosa. In both disorders, the retinal phenotype involves progressive rod photoreceptor loss resulting in nyctalopia and a constricted visual field, followed by subsequent cone degeneration, leading to the loss of central vision and severe visual impairment. The USH2A gene raises many challenges for researchers and clinicians due to a broad spectrum of mutations, a large gene size hampering gene therapy development and limited knowledge on its pathogenicity. Patients with Usher type 2 may benefit from hearing aids or cochlear implants to correct their hearing defects, but there are currently no approved treatments available for the USH2A-retinopathy. Several treatment strategies, including antisense oligonucleotides and translational readthrough inducing drugs, have shown therapeutic promise in preclinical studies. Further understanding of the pathogenesis and natural history of USH2A-related disorders is required to develop innovative treatments and design clinical trials based on reliable outcome measures. The present review will discuss the current knowledge about USH2A, the emerging therapeutics and existing challenges

Generation of two human iPSC lines from patients with autosomal dominant retinitis pigmentosa (UCLi014-A) and autosomal recessive Leber congenital amaurosis (UCLi015-A), associated with RDH12 variants

Induced pluripotent stem cell (iPSC) lines were generated from two patients with RDH12 variants. UCLi014-A is from a patient with heterozygous frameshift mutation c.759del p.(Phe254Leufs*24), associated with autosomal dominant retinitis pigmentosa. UCLi015-A is from a patient with homozygous missense mutation c.619A > G p.(Asn207Asp), associated with Leber congenital amaurosis. Fibroblasts were derived from skin biopsies and reprogrammed using integration free episomal reprogramming plasmids. The iPSC lines expressed pluripotency markers, exhibited differentiation potential in vitro and displayed normal karyotypes. These cell lines will act as a tool for disease modelling, enabling comparison of disease mechanisms, identification of therapeutic targets and drug screening

Generation of human iPSC line (UCLi013-A) from a patient with microphthalmia and aniridia, carrying a heterozygous missense mutation c.372C>A p.(Asn124Lys) in PAX6

A human induced pluripotent stem cell (hiPSC) line (UCLi013-A) was generated from fibroblast cells of a 34-year-old donor with multiple ocular conditions including severe microphthalmia and aniridia. The patient had a heterozygous missense mutation in PAX6 c.372C>A, p.(Asn124Lys), validated in the fibroblasts through Sanger sequencing. Fibroblasts derived from a skin biopsy were reprogrammed using integration free episomal reprogramming. The established iPSC line was found to express pluripotency markers, exhibit differentiation potential in vitro and display a normal karyotype. This cell line will act as a tool for disease modelling of microphthalmia and aniridia, identification of therapeutic targets and drug screening

Macroscopic and microscopic determinations of residual stresses in thin Oxide Dispersion Strengthened steel tubes

To improve the efficiency of components operating at high temperatures, many efforts are deployed to develop new materials. Oxide Dispersion Strengthened (ODS) materials could be used for heat exchangers or cladding tubes for the new GENIV nuclear reactors. This type of materials are composed with a metallic matrix (usually iron base alloy for nuclear applications or nickel base alloy for heat exchangers) reinforced by a distribution of nano-oxides. They are obtained by powder metallurgy and mechanical alloying. The creep resistance of these materials is excellent, and they usually exhibit a high tensile strength at room temperature. Depending on the cold working and/or the heat treatments, several types of microstructure can be obtained: recrystallised, stress relieved. One of the key challenges is to transform ODS materials into thin tubes (up to 500 microns thick) within a robust fabrication route while keeping the excellent mechanical properties. To prevent cracking during the process or to obtain a final product with low residual stresses, it is important to quantify the effect of the heat treatments on the release of internal stresses. The aim of this study is to show how residual stresses can be determined on different thin tubes using two complementary approaches: (i) macroscopic stresses determination in the tube using beam theory (small cuts along the longitudinal and circumferential directions and measurements of the deflection), (ii) stress determination from X-ray diffraction analyses (surface analyses, using "sin 2 Ψ" method with different hypothesis). Depending on the material and the heat treatment, residual stresses vary dramatically and can reach 800 MPa which is not far from the yield stress; comparisons between both methods are performed and suggestions are given in order to optimize the thermo-mechanical treatment of thin ODS tubes

A calibration procedure for the assessment of work hardening part I: Effects of the microstructure and load type

This paper presents a methodology to define and quantify the level of work hardening locally in a material. The methodology is proposed after a thorough experimental study based on three complementary experimental techniques for microstructural characterizations: microhardness, X-ray diffraction (XRD) and Electron Backscatter Diffraction (EBSD) applied on Inconel 718 samples. In our analysis, several loading histories including single tension, single compression, high strain rates and low cycle fatigue have been investigated. The effects of the microstructure have been further investigated by modifying the size of the grains and the size of the strengthening precipitates. Experimental tests have also been simulated to choose a model variable able to represent work hardening. A reciprocal link between work hardening and experimental characterizations has then been established. Correlation curves have been proposed that enable to quantify the level of work hardening from the knowledge of the experimental data. Accuracy and complementarity of the three experimental approaches are discussed as well as the impact of the microstructure of the material on the measured quantities

A calibration procedure for the assessment of work hardening Part II: Application to shot peened IN718 parts

The objective of this paper is to discuss the application of the calibration methodology exposed in the previous part to shot-peened Inconel 718 specimens. Shot peening is commonly used to increase the fatigue life of critical parts such as Inconel 718 turbine discs. This surface treatment induces residual stresses, work hardening and possibly, gradients of microstructures that, in turn, affect fatigue life. Work hardening is a quantity that represents a set of physical and mechanical phenomena related to the level of disorder reached in the microstructure of the material. Work hardening is seldom taken into account in fatigue life assessment mainly because it is not possible to characterize this quantity directly. We propose to use the calibration methodology (see part I of this paper [1]) on samples shot peened with several conditions. The three complementary experimental techniques (microhardness, XRD and EBSD) are then used to determine through correlation curves the work hardening gradients. The meth-odology for characterizing the work hardening within shot peened specimens is first presented. A dis-cussion of the applicability of the method in this context is then provided. The results obtained for the different characterization methods and microstructural effects are analyzed in two different sections. Finally, the influence of shot peening conditions on residual stresses and on work hardening is dis-cussed, showing the interest of the proposed procedure to obtain a real picture of the mechanical state after shot peening

Incorporation of Y2O3 Particles into 410L Stainless Steel by a Powder Metallurgy Route

Addition of yttria to steels has been proposed for the fabrication of oxide-dispersion-strengthened materials for nuclear power applications. We have investigated materials prepared from 12 Cr martensitic stainless steel, AISI 410L, produced by powder metallurgy. Materials were produced with and without yttria addition, and two different sizes of yttria were used, 0.9 µm and 50 nm. Tensile and mini-creep tests were performed to determine mechanical properties. Optical microscopy, SEM, TEM, and EDX analysis were used to investigate the microstructures and deformation mechanisms and to obtain information about non-metallic inclusion particles. SiO2, MnS, and Y2Si2O7 inclusion particles were observed. An SiO2 and Y2O3 interaction was seen to have occurred during the ball milling, which impaired the final mechanical properties. Small-angle neutron scattering experiments showed that the matrix chemistry prevented effective dissolution of the yttria. © The Author(s) 201

Identification of β-catenin binding regions in colon cancer cells using ChIP-Seq

Deregulation of the Wnt/β-catenin signaling pathway is a hallmark of colon cancer. Mutations in the adenomatous polyposis coli (APC) gene occur in the vast majority of colorectal cancers and are an initiating event in cellular transformation. Cells harboring mutant APC contain elevated levels of the β-catenin transcription coactivator in the nucleus which leads to abnormal expression of genes controlled by β-catenin/T-cell factor 4 (TCF4) complexes. Here, we use chromatin immunoprecipitation coupled with massively parallel sequencing (ChIP-Seq) to identify β-catenin binding regions in HCT116 human colon cancer cells. We localized 2168 β-catenin enriched regions using a concordance approach for integrating the output from multiple peak alignment algorithms. Motif discovery algorithms found a core TCF4 motif (T/A–T/A–C–A–A–A–G), an extended TCF4 motif (A/T/G–C/G–T/A–T/A–C–A–A–A–G) and an AP-1 motif (T–G–A–C/T–T–C–A) to be significantly represented in β-catenin enriched regions. Furthermore, 417 regions contained both TCF4 and AP-1 motifs. Genes associated with TCF4 and AP-1 motifs bound β-catenin, TCF4 and c-Jun in vivo and were activated by Wnt signaling and serum growth factors. Our work provides evidence that Wnt/β-catenin and mitogen signaling pathways intersect directly to regulate a defined set of target genes

Multiple Wnt/ß-Catenin Responsive Enhancers Align with the MYC Promoter through Long-Range Chromatin Loops

Inappropriate activation of c-Myc (MYC) gene expression by the Wnt/ß-catenin signaling pathway is required for colorectal carcinogenesis. The elevated MYC levels in colon cancer cells are attributed in part to ß-catenin/TCF4 transcription complexes that are assembled at proximal Wnt/ß-catenin responsive enhancers (WREs). Recent studies suggest that additional WREs that control MYC expression reside far upstream of the MYC transcription start site. Here, I report the characterization of five novel WREs that localize to a region over 400 kb upstream from MYC. These WREs harbor nucleosomes with post-translational histone modifications that demarcate enhancer and gene promoter regions. Using quantitative chromatin conformation capture, I show that the distal WREs are aligned with the MYC promoter through large chromatin loops. The chromatin loops are not restricted to colon cancer cells, but are also found in kidney epithelial and lung fibroblast cell lines that lack de-regulated Wnt signaling and nuclear ß-catenin/TCF4 complexes. While each chromatin loop is detected in quiescent cells, the positioning of three of the five distal enhancers with the MYC promoter is induced by serum mitogens. These findings suggest that the architecture of the MYC promoter is comprised of distal elements that are juxtaposed through large chromatin loops and that ß-catenin/TCF4 complexes utilize this conformation to activate MYC expression in colon cancer cells